期刊文献+

产超广谱β-内酰胺酶大肠埃希菌感染的危险因素分析 被引量:11

Risk factors for infections caused by extended-spectrum β-lactamase-producing Escherichia coli
原文传递
导出
摘要 目的分析产超广谱β-内酰胺酶(ESBLs)大肠埃希菌(ECO)的临床特征,评估其感染危险因素,为制定预防医院感染策略提供科学依据。方法采用病例对照研究,收集医院2013年3-6月住院患者送检标本检出的非重复ECO 278株,采用VITEK-2Compact全自动微生物分析仪进行细菌鉴定及药敏试验,采用双纸片协同试验对检测出的产ESBLs-ECO进行确证试验,采用χ2检验和logistic回归模型对产ESBLs-ECO感染危险因素进行统计分析。结果 278株ECO中产ESBLs-ECO 172株,占61.9%;产ESBLs-ECO主要分离自尿液、分泌物和血液,病房分布主要以泌尿外科、妇科和胃肠外科为主,分别占15.7%、14.0%、11.7%;住院>10d、手术、灌肠、导尿置管、引流置管、使用皮质激素、使用抗菌药物(尤其头孢类药物)是产ESBLs-ECO医院感染的主要危险因素(P<0.05);引流置管和头孢类药物使用为独立危险因素。结论产ESBLs-ECO检出率较高,医院应根据危险因素加强医院感染管理,尤其是规范引流管操作和慎用头孢类抗菌药物,减少产ESBLs-ECO感染的发生。 OBJECTIVE To analyze the clinical characteristics of extended‐spectrum β‐lactamase (ESBLs)‐producing Escherichia coli and observe the risk factors for infections so as to provide scientific basis for prevention of nosoco‐mial infection .METHODS By means of case‐control study ,totally 278 strains of non‐repetitive E .coli were isolated from the submitted specimens that were obtained from the patients who were hospitalized from Mar 2013 to Jun 2013 ,then the bacterial identification was carried out by using VITEK‐2 Compact automatic microorganism analy‐zer ,the drug susceptibility testing was performed ,the confirmatory test was conducted for the isolated ESBLs‐producing E .coli with the use of double disk synergy test ,and the risk factors for the ESBLs‐producing E .coli in‐fections were statistically analyzed by using the chi‐square test and logistic regression model .RESULTS A total of 172 strains of ESBLs‐producing E .coli were identified among the 278 strains of E .coli ,accounting for 61 .9% . The ESBLs‐producing E .coli strains were mainly isolated from the urine ,secretions ,and blood .Among the isola‐ted ESBLs‐producing E .coli strains ,15 .7% were isolated from the urology department ,14 .0% from the gynecol‐ogy department ,11 .7% from the gastroenterology department .The leading risk factors for the ESBLs‐producing E .coli infections included the length of hospital stay more than 10 days ,surgery ,clyster ,urinary catheterization , drainage intubation ,use of corticosteroids ,and use of antibiotics ,cephalosporins in particularly (P〈0 .05);the drainage intubation and use of cephalosporins were the independent risk factors .CONCLUSION The isolation rate of the ESBLs‐producing E .coli is high .It is necessary for the hospital to strengthen the control of nosocomial in‐fections according to the risk factors ,focus on the standard operation of drainage tubes ,and reasonably use cepha‐losporins so as to reduce the incidence of ESBLs‐producing E .coli infections .
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2015年第5期1001-1003,共3页 Chinese Journal of Nosocomiology
基金 国家临床重点专科建设基金资助项目(财社2010(305))
关键词 超广谱Β-内酰胺酶 大肠埃希菌 医院感染 危险因素 Extended-spectrum β-lactamase Escherichia coli Nosocomial infection Risk factor
  • 相关文献

参考文献7

二级参考文献32

  • 1刘学东,胡必杰,高晓东,倪才妹,谢红梅.大肠埃希菌的耐药特性及其产超广谱β-内酰胺酶的分析[J].基础医学与临床,2004,24(3):314-316. 被引量:12
  • 2吴金英,李岩斌,王士忠,苏兆兰.大肠埃希菌感染的临床分布与耐药性[J].中华医院感染学杂志,2004,14(7):826-827. 被引量:30
  • 3骆雪萍,孔晋亮,陈一强.呼吸机相关肺炎病原菌流行特征及病原菌产ESBLs的相关因素分析[J].广西医科大学学报,2006,23(3):433-435. 被引量:8
  • 4黄瑞娟,叶临湘,冯启明.大肠埃希菌产超广谱β-内酰胺酶危险因素病例对照研究[J].中国感染控制杂志,2007,6(4):235-238. 被引量:20
  • 5卫生部办公厅.卫生部办公厅关于进一步加强抗菌药物临床应用管理的通知(卫办医发[2008]48号)附件2卫生部全国细菌耐药监测2006-2007年度报告[R].2008-03-24.
  • 6Oteo J, Campos J, Baquero F, et al.Antibiotic resistance in 1 962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Re- sistance Surveillance System(2001 )[J]. J Antimicrob Che- mother, 2002,50(6) :945.
  • 7National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibili ty test. Approved standard M2-A6(M100S7) [ S]. 6 th edition. Wayne, PA NCCLS, 2003.
  • 8Tumbarello M, Spanu T, Di Bidino R, et al. Costs of blood- stream infections caused by Escherichia coli and influence of ex- tended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy [J]. Antimicrob Agents Chemother, 2010, 54(10): 4085-4091.
  • 9Dhillon RHP, Clark J. ESBLs: A Clear and Present Danger [J/ OL]. http: //www.hindawi.eom/joumals/eerp/2012/625170/.
  • 10Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update [J]. Clin Microbiol Rev, 2005, 18(4) : 657- 686.

共引文献43

同被引文献95

引证文献11

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部